[Hepatic drug monitoring in patients exposed to antitubercular treatment].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000410:Alanine Transaminase / Q000097:blood; D000437:Alcoholism / Q000150:complications; D000995:Antitubercular Agents / Q000009:adverse effects* / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury; D005260:Female; D006801:Humans; D006932:Hyperbilirubinemia / Q000209:etiology; D008107:Liver Diseases / Q000097:blood; D008108:Liver Diseases, Alcoholic / Q000150:complications; D008297:Male; D008875:Middle Aged; D014376:Tuberculosis / Q000150:complications / Q000188:drug therapy*
D000995:Antitubercular Agents; D000410:Alanine Transaminase
Farmacovigilancia hepática de pacientes sometidos a tratamiento antituberculoso.